FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996367807> ?p ?o ?g. }

• W1996367807 endingPage "134" @default.
• W1996367807 startingPage "121" @default.
• W1996367807 abstract "In order to determine the effects on plasma lipoproteins of oral contraceptives containing progestins with varying androgenic potency, 136 healthy women were randomized into 3 groups and followed prospectively for one year while receiving either 50 mcg ethinyl estradiol and 1.0 mg ethynodiol diacetate (EED), 50 mcg ethinyl estradiol and 1.0 mg norethindrone acetate (ENA), or 50 mcg ethinyl estradiol and 0.5 mg d-1 norgestrel (ENG). Comparison was made to a self-selected group of 50 women using alternative means of contraception. Plasma cholesterol increased by 7-9% and triglycerides by 32-57% in all 3 groups (p less than 0.05). ENG use resulted in other significant lipoprotein changes including an 18% increase in low density lipoprotein cholesterol (LDL-C), a 13% fall in high density lipoprotein cholesterol (HDL-C) and a 27% decline in HDL2 cholesterol (HDL2-C) (p less than 0.05). Apoprotein A-I (Apo A-I) increased by 9% with ENA and by 11% with EED (p less than 0.05), but did not change significantly with ENG. This prospective study demonstrates that in oral contraceptive agents with identical estrogen, progestins with different androgenic potency produce major and different changes in plasma lipoproteins.In order to determine the effects on plasma lipoproteins of oral contraceptives containing progestins with varying androgenic potency, 136 healthy women were randomized into 3 groups and followed prospectively for 1 year while receiving either 50 mcg ethinyl estradiol and 1.0 mg ethynodiol diacetate (EED), 50 mcg ethinyl estradiol and 1.0 mg norethindrone acetate (ENA), or 50 mcg ethinyl estradiol and 0.5 mg d-1 norgestrel (ENG). Comparison was made to a self-selected group of 50 women using alternative means of contraception. Plasma cholesterol increased by 7-9% and triglycerides by 32-57% in all 3 groups. ENG use resulted in other significant lipoprotein changes including an 18% increase in low density lipoprotein cholesterol, a 13% fall in high density lipoprotein cholesterol and a 27% decline in high density lipoprotein-2 cholesterol. Apoprotein A-1 increased by 9% with ENA and by 11% with EED, but did not change significantly with ENG. Khis prospective study demonstrates that in oral contraceptive agents with identical estrogen, progestins with different androgenic potency produce major and different changes in plasms lipoproteins." @default.
• W1996367807 created "2016-06-24" @default.
• W1996367807 creator A5019467851 @default.
• W1996367807 creator A5036769436 @default.
• W1996367807 creator A5054570273 @default.
• W1996367807 creator A5062427783 @default.
• W1996367807 creator A5068584343 @default.
• W1996367807 creator A5073353651 @default.
• W1996367807 creator A5088276086 @default.
• W1996367807 creator A5091074550 @default.
• W1996367807 date "1986-08-01" @default.
• W1996367807 modified "2023-09-27" @default.
• W1996367807 title "Progestins and oral contraceptive-induced lipoprotein changes: A prospective study" @default.
• W1996367807 cites W1687166224 @default.
• W1996367807 cites W1878925879 @default.
• W1996367807 cites W1919566310 @default.
• W1996367807 cites W1970546892 @default.
• W1996367807 cites W1971353306 @default.
• W1996367807 cites W1975344535 @default.
• W1996367807 cites W2031731441 @default.
• W1996367807 cites W2032475772 @default.
• W1996367807 cites W2034842825 @default.
• W1996367807 cites W2047924415 @default.
• W1996367807 cites W2054097500 @default.
• W1996367807 cites W2054452226 @default.
• W1996367807 cites W2058086004 @default.
• W1996367807 cites W2066315702 @default.
• W1996367807 cites W2071349273 @default.
• W1996367807 cites W2073018115 @default.
• W1996367807 cites W2077274405 @default.
• W1996367807 cites W2083058051 @default.
• W1996367807 cites W2084166980 @default.
• W1996367807 cites W2087015989 @default.
• W1996367807 cites W2088416370 @default.
• W1996367807 cites W2094822609 @default.
• W1996367807 cites W2116404316 @default.
• W1996367807 cites W2336559915 @default.
• W1996367807 cites W2338124628 @default.
• W1996367807 cites W27472189 @default.
• W1996367807 cites W4243841175 @default.
• W1996367807 cites W4244451369 @default.
• W1996367807 doi "https://doi.org/10.1016/0010-7824(86)90065-x" @default.
• W1996367807 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3096633" @default.
• W1996367807 hasPublicationYear "1986" @default.
• W1996367807 type Work @default.
• W1996367807 sameAs 1996367807 @default.
• W1996367807 citedByCount "61" @default.
• W1996367807 countsByYear W19963678072012 @default.
• W1996367807 countsByYear W19963678072017 @default.
• W1996367807 countsByYear W19963678072021 @default.
• W1996367807 crossrefType "journal-article" @default.
• W1996367807 hasAuthorship W1996367807A5019467851 @default.
• W1996367807 hasAuthorship W1996367807A5036769436 @default.
• W1996367807 hasAuthorship W1996367807A5054570273 @default.
• W1996367807 hasAuthorship W1996367807A5062427783 @default.
• W1996367807 hasAuthorship W1996367807A5068584343 @default.
• W1996367807 hasAuthorship W1996367807A5073353651 @default.
• W1996367807 hasAuthorship W1996367807A5088276086 @default.
• W1996367807 hasAuthorship W1996367807A5091074550 @default.
• W1996367807 hasConcept C126322002 @default.
• W1996367807 hasConcept C134018914 @default.
• W1996367807 hasConcept C185592680 @default.
• W1996367807 hasConcept C202751555 @default.
• W1996367807 hasConcept C2777164284 @default.
• W1996367807 hasConcept C2778163477 @default.
• W1996367807 hasConcept C2778462979 @default.
• W1996367807 hasConcept C2779076696 @default.
• W1996367807 hasConcept C2779496863 @default.
• W1996367807 hasConcept C2780072125 @default.
• W1996367807 hasConcept C2780186607 @default.
• W1996367807 hasConcept C2908647359 @default.
• W1996367807 hasConcept C2986817661 @default.
• W1996367807 hasConcept C55493867 @default.
• W1996367807 hasConcept C57992300 @default.
• W1996367807 hasConcept C71924100 @default.
• W1996367807 hasConcept C99454951 @default.
• W1996367807 hasConceptScore W1996367807C126322002 @default.
• W1996367807 hasConceptScore W1996367807C134018914 @default.
• W1996367807 hasConceptScore W1996367807C185592680 @default.
• W1996367807 hasConceptScore W1996367807C202751555 @default.
• W1996367807 hasConceptScore W1996367807C2777164284 @default.
• W1996367807 hasConceptScore W1996367807C2778163477 @default.
• W1996367807 hasConceptScore W1996367807C2778462979 @default.
• W1996367807 hasConceptScore W1996367807C2779076696 @default.
• W1996367807 hasConceptScore W1996367807C2779496863 @default.
• W1996367807 hasConceptScore W1996367807C2780072125 @default.
• W1996367807 hasConceptScore W1996367807C2780186607 @default.
• W1996367807 hasConceptScore W1996367807C2908647359 @default.
• W1996367807 hasConceptScore W1996367807C2986817661 @default.
• W1996367807 hasConceptScore W1996367807C55493867 @default.
• W1996367807 hasConceptScore W1996367807C57992300 @default.
• W1996367807 hasConceptScore W1996367807C71924100 @default.
• W1996367807 hasConceptScore W1996367807C99454951 @default.
• W1996367807 hasIssue "2" @default.
• W1996367807 hasLocation W19963678071 @default.
• W1996367807 hasLocation W19963678072 @default.
• W1996367807 hasOpenAccess W1996367807 @default.
• W1996367807 hasPrimaryLocation W19963678071 @default.

• next